Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Annals of Hematology|October 8, 2024
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriersAlessandro Laganà, Silvia Sorella, Ludovica Fucci, et al.
Journal of Thrombosis and Thrombolysis|March 1, 2020
Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulantsAlessandra Serrao, Benedetta Lucani, Giovanni Assanto Manfredi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 11, 2019
Correction to: Plasma Vitamin K1 Levels in Italian Patients Receiving Oral Anticoagulant Therapy for Mechanical Heart Prosthesis: A Case-Control StudyArturo Cafolla, Alessandra Gentili, Clodomiro Cafolla, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 17, 2016
Plasma Vitamin K1 Levels in Italian Patients Receiving Oral Anticoagulant Therapy for Mechanical Heart Prosthesis: A Case-Control StudyArturo Cafolla, Alessandra Gentili, Clodomiro Cafolla, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 17, 2019
Direct Oral Anticoagulants in Patients Affected by Major Congenital ThrombophiliaAlessandra Serrao, Benedetta Lucani, Davide Mansour, et al.
Patient Preference and Adherence|February 19, 2019
Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia AGiovanni Di Minno, Elena Santagostino, Massimo Morfini, et al.
Clinical Case Reports|August 8, 2017
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing caseCristina Santoro, Paola Volpicelli, Erminia Baldacci, et al.
European Journal of Haematology|November 1, 2016
TPO-RAs in pITP: description of a case series and analysis of predictive factors for responseMaria Gabriella Mazzucconi, Cristina Santoro, Erminia Baldacci, et al.
Acta Haematologica|December 21, 2013
Rituximab in previously treated primary immune thrombocytopenia patients: evaluation of short- and long-term efficacy and safetyCristina Santoro, Francesca Biondo, Erminia Baldacci, et al.
Pageof 5